JP2013533875A5 - - Google Patents

Download PDF

Info

Publication number
JP2013533875A5
JP2013533875A5 JP2013518254A JP2013518254A JP2013533875A5 JP 2013533875 A5 JP2013533875 A5 JP 2013533875A5 JP 2013518254 A JP2013518254 A JP 2013518254A JP 2013518254 A JP2013518254 A JP 2013518254A JP 2013533875 A5 JP2013533875 A5 JP 2013533875A5
Authority
JP
Japan
Prior art keywords
facviia
immunoglobulin
region
facvii
conjugate according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013518254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013533875A (ja
Filing date
Publication date
Priority claimed from KR1020100062860A external-priority patent/KR20120002129A/ko
Application filed filed Critical
Publication of JP2013533875A publication Critical patent/JP2013533875A/ja
Publication of JP2013533875A5 publication Critical patent/JP2013533875A5/ja
Pending legal-status Critical Current

Links

JP2013518254A 2010-06-30 2011-06-30 免疫グロブリン断片を用いた第7因子(FactorVIIa)薬物結合体 Pending JP2013533875A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2010-0062860 2010-06-30
KR1020100062860A KR20120002129A (ko) 2010-06-30 2010-06-30 면역글로불린 단편을 이용한 제7인자(Factor Ⅶa)약물 결합체
PCT/KR2011/004796 WO2012002745A2 (en) 2010-06-30 2011-06-30 Factor viia complex using an immunoglobulin fragment

Publications (2)

Publication Number Publication Date
JP2013533875A JP2013533875A (ja) 2013-08-29
JP2013533875A5 true JP2013533875A5 (cg-RX-API-DMAC7.html) 2014-06-26

Family

ID=45402578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518254A Pending JP2013533875A (ja) 2010-06-30 2011-06-30 免疫グロブリン断片を用いた第7因子(FactorVIIa)薬物結合体

Country Status (8)

Country Link
US (1) US20130095090A1 (cg-RX-API-DMAC7.html)
EP (1) EP2588142A2 (cg-RX-API-DMAC7.html)
JP (1) JP2013533875A (cg-RX-API-DMAC7.html)
KR (1) KR20120002129A (cg-RX-API-DMAC7.html)
CN (1) CN103025358A (cg-RX-API-DMAC7.html)
AR (1) AR082032A1 (cg-RX-API-DMAC7.html)
TW (1) TWI443106B (cg-RX-API-DMAC7.html)
WO (1) WO2012002745A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0406605B8 (pt) * 2003-11-13 2021-05-25 Hanmi Holdings Co Ltd conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
CN104774269B (zh) * 2013-08-16 2016-02-24 安源生物科技(上海)有限公司 改良型人凝血因子FVII-Fc融合蛋白及其制备方法与用途
JP2017513831A (ja) * 2014-04-11 2017-06-01 シーエスエル、リミテッド 出血の予防および処置のための半減期延長型(half−life extended)第fviia因子タンパク質、ならびに、その投与レジメン
WO2017127679A1 (en) * 2016-01-21 2017-07-27 Protein Dynamic Solutions Llc Method and system for spectral data analysis
KR101892687B1 (ko) 2017-05-18 2018-08-28 세종대학교산학협력단 하이드라진 연료전지용 전극과 이를 포함하는 막 전극 접합체 및 연료전지
CN111849945B (zh) * 2019-04-25 2024-11-29 正大天晴药业集团股份有限公司 人凝血因子VIIa的纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656158B1 (en) * 2003-08-14 2016-03-09 Novo Nordisk Health Care AG Liquid, aqueous pharmaceutical composition of factor vii polypeptides
EP1673453A2 (en) * 2003-10-07 2006-06-28 Novo Nordisk Health Care AG Hybrid molecules having factor vii/viia activity
BRPI0406605B8 (pt) * 2003-11-13 2021-05-25 Hanmi Holdings Co Ltd conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
MX2008002395A (es) * 2005-08-19 2008-03-18 Neose Technologies Inc Factor vii y factor viia glicopegilados.
WO2007140282A1 (en) * 2006-05-24 2007-12-06 Peg Biosciences Peg linker compounds and biologically active conjugates thereof
US20100056428A1 (en) * 2006-09-01 2010-03-04 Novo Nordisk Health Care Ag Modified proteins
EP2300501B1 (en) * 2008-07-23 2014-08-20 Hanmi Science Co., Ltd. A polypeptide complex comprising non-peptidyl polymer having three functional ends

Similar Documents

Publication Publication Date Title
JP2015503554A5 (cg-RX-API-DMAC7.html)
RU2012146663A (ru) Конъюгат инсулина с применением фрагмента иммуноглобулина
JP2015510880A5 (cg-RX-API-DMAC7.html)
RU2015138536A (ru) Новый аналог инсулина и его применение
JP2017529354A5 (cg-RX-API-DMAC7.html)
Liu et al. Recent advances in materials for hemostatic management
RU2014108725A (ru) Фармацевтическая композиция для лечения рака, содержащая конъюгат интерферона-альфа
JP2022025114A5 (cg-RX-API-DMAC7.html)
RU2014133615A (ru) Фармацевтическая композиция для предупреждения или лечения неалкогольной жировой болезни печени
RU2015133462A (ru) Сайт-специфичный конъюгат инсулина
US20190160160A1 (en) Methods to Treat Diseases with Protein, Peptide and Antigen Modification
RU2670748C2 (ru) Конъюгаты антител с лекарственными агентами, обладающие улучшенной стабильностью, и их применение
EP2354163A3 (en) Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies
JP2015536943A5 (cg-RX-API-DMAC7.html)
KR101648960B1 (ko) 접합 물질과 코티닌과의 접합체에 항-코티닌 항체가 결합된 복합체 및 이의 용도
EP4279140A3 (en) Human antibodies against tissue factor
BR112017013661B1 (pt) Conjugado de proteína de ligação-fármaco e composição farmacêutica
WO2010111018A8 (en) Antibody drug conjugates (adc) that bind to 24p4c12 proteins
JP2010519182A (ja) 多量体接合体
UA98153C2 (uk) Цитотоксичний засіб, що включає похідні томайміцину, і його терапевтичне застосування
WO2009061996A3 (en) Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
AR048098A1 (es) Conjugados de caliqueamicina
EP3539988A3 (en) Monoclonal antibodies against her2
JP2015533847A (ja) 新規薬物−タンパク質コンジュゲート
WO2007100385A3 (en) Macrocyclic depsipeptide antibody-drug conjugates and methods